Federal Register / Vol. 88, No. 171 / Wednesday, September 6, 2023 / Notices 60987 

The District desires to enter into a 

Section 14 of the Reclamation Projects 

Act of 1939 contract for Reclamation to 

dedicate a water right in order for the 

Utah State Parks to receive water at the 

Rock Cliff Recreation Area for 

recreational purposes. 

42. Los Ranchitos Estates, Florida 

Project, Colorado: Reclamation received 

a request for a long-term water service 

contract (25 years) to augment 

depletions from residential water uses 

within the subdivision. The proposed 

contract will be for 36 acre-feet of water 

annually. 

43. Forrest Groves Estates, Florida 

Project, Colorado: Reclamation received 

a request for a long-term water service 

contract (25 years) to augment 

depletions from residential water uses 

within the subdivision. The proposed 

contract will be for 43 acre-feet of water 

annually. 

44. Country Aire Estates, Florida 

Project, Colorado: Reclamation received 

a request for a long-term water service 

contract (25 years) to augment 

depletions from residential water uses 

within the subdivision. The proposed 

contract will be for 7 acre-feet of water 

annually. 

LOWER COLORADO BASIN— 

INTERIOR REGION 8: Bureau of 

Reclamation, P.O. Box 61470 (Nevada 

Highway and Park Street), Boulder City, 

Nevada 89006–1470, telephone 702– 

293–8192. 

Completed contract actions: 

16. GSC Farm, LLC, and the Town of 

Queen Creek, Arizona; BCP; Arizona: 

Enter into a proposed partial assignment 

and transfer of Arizona fourth-priority 

Colorado River water in the amount of 

2,033.01 acre-feet per year from GSC to 

Queen Creek, amend GSC’s Colorado 

River water delivery contract No. 13– 

XX–30–W0571 to decrease their 

Colorado River water entitlement from 

2,913.3 to 69.93 acre-feet per year, enter 

into Colorado River water delivery 

contract No. 20–XX–30–W0689 with 

Queen Creek for 2,033.01 acre-feet per 

year of Arizona fourth-priority Colorado 

River water entitlement, and enter into 

a wheeling agreement between the 

United States and Queen Creek for the 

wheeling of non-project water to be 

transported through the CAP for the use 

or benefit of Queen Creek. Contracts 

executed on April 28, 2023. 

19. Western Water, LLC and Cibola 

Valley IDD, BCP, Arizona: Approve an 

amendment of Western’s contract 

service area under their contract No. 16– 

XX–30–W0619, as amended (Western 

Contract), to include the previously 

excluded parcels of land; namely, the 

eastern halves of Assessor Parcel Nos. 

301–08–003C and 301–08–003D. The 

inclusion of these lands within the 

Western Contract service area will make 

these lands eligible to receive Arizona 

fourth-priority Colorado River water 

from Western. Western has an Arizona 

fourth-priority Colorado River water 

entitlement under the Western Contract 

for an annual diversion of 536.48 acrefeet of Colorado River water for 

irrigation use within the Western 

Contract service area. Additionally, 

Reclamation will amend the District’s 

contract service area under their 

contract to exclude Western lands. The 

exclusion of the Western lands from the 

District’s contract service area will make 

the Western lands ineligible to receive 

Arizona fourth-, fifth-, and/or sixthpriority water from the District. The 

District’s boundary will remain the 

same. Contracts executed on April 18, 

2023. 

COLUMBIA–PACIFIC 

NORTHWEST—INTERIOR REGION 9: 

Bureau of Reclamation, 1150 North 

Curtis Road, Suite 100, Boise, Idaho 

83706–1234, telephone 208–378–5344. 

Modified contract action: 

16. Storage Division, Yakima Project, 

Washington: Contracts with water user 

entities for the repayment of 

reimbursable shares of the costs of the 

SOD program modification for Kachess 

Dam. 

CALIFORNIA–GREAT BASIN— 

INTERIOR REGION 10: Bureau of 

Reclamation, 2800 Cottage Way, 

Sacramento, California 95825–1898, 

telephone 916–978–5250. 

Completed contract action: 

9. San Luis WD, CVP, California: 

Proposed partial assignment of 4,449 

acre-feet of the District’s CVP supply to 

Santa Nella County WD for M&I use. 

Contract executed on January 24, 2023. 

Christopher Beardsley, 

Director, Policy and Programs. 

[FR Doc. 2023–19132 Filed 9–5–23; 8:45 am] 

BILLING CODE 4332–90–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1176] 

Bulk Manufacturer of Controlled 

Substances Application: SpecGx LLC; 

Correction 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice; correction. 

SUMMARY: The Drug Enforcement 

Administration (DEA) published a 

document in the Federal Register of 

April 4, 2023, concerning a notice of 

application for bulk manufacturer of 

Controlled Substances. That document 

listed a drug code/controlled substance 

in error as it was not requested by the 

registrant (2270—Pentobarbital). 

Additionally, the document listed 

duplicates of 7 other drug codes in error 

(1100, 1105, 1205, 1724, 8333, 9780, 

9801). 

SUPPLEMENTARY INFORMATION: 

Correction 

In the Federal Register of April 4, 

2023, in FR Doc. 2023–06952 (88 FR 

19990), on page 19990, in columns 1 

and 2, under the requested controlled 

substances/drug codes, it should read as 

such: 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid.

2010 I 

Tetrahydrocannabinols ... 7370 I 

Psilocybin ....................... 7437 I 

Codeine-N-oxide ............. 9053 I 

Noroxymorphone ............ 9145 I 

Difenoxin ......................... 9168 I 

Morphine-N-oxide ........... 9307 I 

Normorphine ................... 9313 I 

Alphamethadol ................ 9605 I 

Betamethadol ................. 9609 I 

Norlevorphanol ............... 9634 I 

Acetyl Fentanyl (N-(1- 

phenethylpiperidin-4- 

yl)-N-phenylacetamide).

9821 I 

Butyryl Fentanyl .............. 9822 I 

Fentanyl related-compounds as defined in 

21 CFR 1308.11(h).

9850 I 

Amphetamine ................. 1100 II 

Methamphetamine .......... 1105 II 

Lisdexamfetamine .......... 1205 II 

Methylphenidate ............. 1724 II 

Nabilone ......................... 7379 II 

ANPP (4-Anilino-Nphenethyl-4-piperidine).8333 II 

Phenylacetone ................ 8501 II 

Codeine .......................... 9050 II 

Dihydrocodeine ............... 9120 II 

Oxycodone ..................... 9143 II 

Hydromorphone .............. 9150 II 

Diphenoxylate ................. 9170 II 

Ecgonine ......................... 9180 II 

Hydrocodone .................. 9193 II 

Levorphanol .................... 9220 II 

Isomethadone ................. 9226 II 

Meperidine ...................... 9230 II 

Meperidine intermediateA.9232 II 

Meperidine intermediateB.9233 II 

Meperidine intermediateC.9234 II 

Methadone ...................... 9250 II 

Methadone intermediate 9254 II 

Dextropropoxyphene, 

bulk (non-dosage 

forms).

9273 II 

Morphine ......................... 9300 II 

Oripavine ........................ 9330 II 

Thebaine ......................... 9333 II 

Opium tincture ................ 9630 II 


lotter on DSK11XQN23PROD with NOTICES1
60988 Federal Register / Vol. 88, No. 171 / Wednesday, September 6, 2023 / Notices 

Controlled substance Drug 

code Schedule 

Opium, powdered ........... 9639 II 

Oxymorphone ................. 9652 II 

Noroxymorphone ............ 9668 II 

Alfentanil ......................... 9737 II 

Remifentanil .................... 9739 II 

Sufentanil ........................ 9740 II 

Tapentadol ...................... 9780 II 

Fentanyl .......................... 9801 II 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–19179 Filed 9–5–23; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1252] 

Importer of Controlled Substances 

Application: Catalent Greenville, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Catalent Greenville, Inc. has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 6, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 6, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on August 10, 2023, 

Catalent Greenville, Inc., 1240 Sugg 

Parkway, Greenville, North Carolina 

27834–9006, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Lysergic Acid 

Diethylamide.

7315 I 

The company plans to import the 

above listed controlled substance for 

internal research and to support 

customers research and clinical studies. 

No other activities for this drug codes 

are authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–19180 Filed 9–5–23; 8:45 am] 

BILLING CODE 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1257] 

Importer of Controlled Substances 

Application: Lipomed 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Lipomed has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before October 6, 2023. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 6, 2023. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on July 28, 2023, Lipomed, 

150 Cambridgepark Drive, Suite 705, 

Cambridge, Massachusetts 02140–2300, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug code Schedule 

Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-N thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine ............................ 2780 I 

Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) ........................... 2785 I 

Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine .................................. 2786 I 

Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine .......................... 2788 I 


lotter on DSK11XQN23PROD with NOTICES1